baber/WOPTO huggingface dataset:
Patent NZ-555794-A (NZ)
Title: Harvesting method and apparatus leafy vegetables or legumes
Inventor: ERHART WENDY
IPC: A01D91/00
Filed: 2005-12-14
Abstract: A harvesting apparatus comprising a first conveyor (30) for conveying seedling trays (10), a cutting station (40) adjacent the first conveyor (30) to cut the leaves of the seedlings and a second conveyor (41) for taking cut leaves away from the cutting station (40). A stationary plate or grill (82) is placed in the gap (82A) between the first conveyor (30) and the cutting station (40) for supporting the trays (10). The cutting mechanism at the cutting station (40) may be adjustable in height above the plate or grill (82). A method of harvesting leafy vegetables and legumes using this apparatus is also described.
Patent NZ-563371-A (NZ)
Title: Method and device for the production of film bags
Inventor: BRAUER JOCHEN
IPC: B31B19/36
Filed: 2006-05-17
Abstract: Method for the production of film bags 17 that have side folds placed in the shape of a V, and a re-closure having a slide, in a head-side filling opening, having the following method steps a) window-shaped punch-outs 10 that delimit the upper end of the side folds formed later, as well as slide punch-outs 11, are made in a planar film web, b) re-closures 6 consisting of two profile strips that lie on top of one another and are connected with one another, as well as a slide that engages over closure edges of the profile strips in the manner of a rider, are laid onto the planar film web 2, crosswise to the web direction, in such a manner that the slides lie in the slide punch-outs 11, and are connected with the film web 2 at their ends, c) subsequently, the film web 2 is guided through a folding station 7, in which the film web 2 is folded, and front surfaces as well as side folds are formed, d) the re-closures 6 are connected with one front surface by means of a sealing seam, with the inclusion of the upper end of the side folds, e) the film plies that lie on top of one another are connected, with additional sealing seams, to form a continuous bag roll 16 consisting of bag-shaped sections, f) film bags 17 are separated from the continuous bag roll 16.
Patent NZ-571335-A (NZ)
Title: A system and method for programming assembly-line programmable domestic appliances
Inventor: SCHWARZ MARCOS GUILHERME
IPC: G05B19/042
Filed: 2007-03-13
Abstract: A method and system for programming domestic appliances during a manufacturing process is disclosed. The system comprises: a remote programming unit (UR); and a processing unit (UP), integrated into the domestic appliance (EN), containing a reprogrammable processor (PR). The remote programming unit (UR) has a data transmission device (TUR) and the processing unit (UP), containing the reprogrammable processor (PR), has a data receiving device (RUP). The remote programming unit (UR) is loaded with at least one program code to be wirelessly transmitted by the data transmission device (TUR) of the remote programming unit (UR) to the data receiving device (RUP) of the processing unit (UP) containing the reprogrammable processor (PR) of the domestic appliance (EN). The remote programming unit (UR) is configured to transmit the program code at the assembly line as a plurality of domestic appliances (EN) is passed in front of it where the data is transmitted between the data transmission device (TUR) and data reception device (RUP) by a magnetic field generating an induced voltage in the data reception device (RUP).
Patent NZ-571872-A (NZ)
Title: Combination therapies of thiazolidinedione analogues and glucocorticoid agonists
Inventor: COLCA GERARD R
IPC: A61K31/4439
Filed: 2007-03-14
Abstract: Disclosed is a pharmaceutical composition comprising a glucocorticoid agonist selected from hydrocortisone, cortisone acetate, prednisone, prednisolone, methylprednisolone, dexamethasone, betamethasone, triamcinolone, beclometasone, fludrocortisone acetate, deoxycorticosterone acetate, aldoseterone, or combinations thereof and a compound selected from: Compound No.1 (5-{4-[2-(5-ethylpyridin-2-yl)-2-oxoethoxy]benzyl}-1,3-thiazolidine-2,4-dione), Compound No.2 (5-{4-[2-(5-ethylpyridin-2-yl)-(R)-2-hydroxyethoxy]benzyl}-1,3-thiazolidine-2,4-dione and Compound No.3 (5-{4-[2-(5-ethylpyridin-2-yl)-(S)-2-hydroxyethoxy]benzyl}-1,3-thiazolidine-2,4-dione). Also disclosed is the use of compounds 1 - 3 in the treatment of inflammatory diseases e.g. diabetes.
Patent NZ-573110-A (NZ)
Title: Cytokine mediating composition comrpising a denatured protein smaller than 50kDa, zinc chloride, glycine and at least one other metal, metal ion or metal salt thereof
Inventor: EIJKENBOOM MAUD LOUISA JOHANNA MARIA
IPC: A61K33/24
Filed: 2007-04-27
Abstract: Disclosed is a composition comprising: (i) denatured plasma proteins having molecular weights less than 50kDa as determined by SDS-PAGE; (ii) at least one metal selected from the group consisting of sodium, nickel, copper, cobalt, iron, magnesium, manganese, potassium, silver and mercury or a metal ion or metal salt thereof; and (iii) zinc chloride and glycine; wherein said composition on contact with a monocyte suppresses TNF-a secretion from said monocyte as compared to a monocyte not contacted with said composition. Further disclosed is a method of manufacturing said composition comprising: (a) mixing plasma with sodium bicarbonate (NaHCO3 ) and incubating said mixture for sufficient time and at a temperature of no more than 80oC to produce a precipitate; (b) resolubilising said precipitate in the presence of an aqueous solution at a temperature of between about 80oC and about 150oC, wherein either before, during or after the resolubilising step said at least one metal, metal ion or metal salt thereof is admixed; (c) admixing zinc chloride and glycine; and (d) separating a composition as disclosed herein.
Patent NZ-577396-A (NZ)
Title: Aptamer against midkine and use thereof
Inventor: MIYAKAWA SHIN
IPC: C12N15/115
Filed: 2007-11-14
Abstract: Disclosed are aptamers possessing inhibitory activity against midkine. The aptamers comprise nucleotide sequences selected from SEQ ID NOs: 1 to 20, 22 to 33, 35 to 36, 39 to 64 and 66 to 70, as defined in the specification, with the provision that the uracil may be thymine. The disclosed nucleotides contained in the aptamers are such that, (i) the 2'-positions of the pyrimidine nucleotides, whether identical or different, are fluorine atoms or substituted by atoms or groups selected from the group consisting of hydrogen atoms, hydroxy groups and methoxy groups, and (ii) the 2'-positions of the purine nucleotides, whether identical or different, are hydroxy groups or substituted by atoms or groups selected from the group consisting of hydrogen atoms, methoxy groups and fluorine atoms.
Patent NZ-577955-A (NZ)
Title: Pineapple plant named Dole-14
Inventor: YOUNG ROBERTO
IPC: A01H6/22
Filed: 2009-06-25
Abstract: Disclosed is a pineapple variety designated 'Dole-14' selected from progeny resulting from cross-pollinating a flower of pineapple variety 'Mayan Gold 03' with pollen from a plant of pineapple variety 'P-1972', wherein the fruit of said variety has an average Brix greater than about 16, a Brix/acid ratio of 29 or more and a carotenoid content of 9ppm or more.
Patent NZ-579120-A (NZ)
Title: A method of pre-processing and processing cloned digital evidence on a cluster of parallel processing nodes
Inventor: AYERS DANIEL FRANCIS
IPC: G06F15/16
Filed: 2010-11-17
Abstract: A system and method of processing digital evidence is disclosed. The method comprises the steps of: (a) pre-processing cloned digital data stored on a data storage device; (b) storing the pre-processed data on a clustered file system; (c) scheduling processing of the pre-processed data in a work queue; and (d) processing the data on a cluster of parallel processing nodes to obtain processing results.
Patent NZ-581353-A (NZ)
Title: Novel n- (8-heteroaryltetrahydronaphtalene-2yl) or n- (5- heteroarylchromane-3-yl) carboxamide derivatives for the treatment of pain
Inventor: BESIDSKI YEVGENI
IPC: C07D413/12
Filed: 2008-04-22
Abstract: Disclosed are N-(8-heteroaryltetrahydronaphtalene-2yl) or N-(5-heteroarylchromane-3-yl) carboxamide derivative compounds of formula (I), wherein the substituents are as described in the specification. Examples of compounds of formula (I) included: N-[(3S)-5-pyridin-4-yl-3,4-dihydro-2H-chromen-3-yl]-4-(trifluoromethoxy)-benzamide; and 4-{ [(2R)-8-Pyridin-4-yl-1,2,3,4-tetrahydronaphthalen-2-yl]carbamoyl} phenyl trifluoromethanesulfonate. Further disclosed is the use of a compound of formula (I) in the manufacture of a medicament for the treatment of pain, and a pharmaceutical composition comprising a therapeutically effective amount of a compound of formula (I).
Patent NZ-582496-A (NZ)
Title: Synergistic combinations of vr-1 antagonists and cox-2 inhibitors
Inventor: FOX ALYSON
IPC: A61K31/4418
Filed: 2008-07-16
Abstract: A combination of 4-(7-hydroxy-2-isopropyl-4-oxo-4H-quinazolin-3-yl)-benzonitrile and an NSAID that is a COX-2 inhibitor. The combination is used for the treatment of chronic pain, rheumatoid arthritis and osteoarthritis. The NSAID can be diclofenac.
Patent NZ-585483-A (NZ)
Title: Inductive power transfer system with a primary track arrangement with first and second phase conductors with balanced mutal coupling between the conductors
Inventor: COVIC GRANT ANTHONY
IPC: H01F38/14
Filed: 2010-05-19
Abstract: 585483 Disclosed is a multiphase Inductive Power Transfer primary track conductor arrangement suitable for powering EVs through the road. The IPT primary track conductor arrangement has a first phase conductor (14) and a second phase conductor (15), the conductors (14, 15) being arranged substantially in a plane and so as to overlap each other and being arranged such that there is substantially balanced mutual coupling between the phase conductors (14, 15). The power supplies (16) and (17) will be each be synchronised and energised 90 degree out of phase with each other. Preferably they share a common DC bus to ensure any mistuning or VAR loading from the receiver (i.e. the pick-up) is managed. The pitch of the track, p, is the distance between the transverse conductor sections, and this should be fixed to achieve the substantially balanced mutual coupling. As a means to further improve horizontal tolerance, a three phase track topology is also disclosed. An advantage of the proposed unipolar topology, shown in Figures 10(b) and 13(b), is that the pattern can be easily continued at either end by adding additional tracks either side. Provided the power supplies are synchronised, this interleaving enables a long portion of road to be continuously powered. Such a track system can be completely modular with power supplies powering fixed lengths of track in the order of 10's of metres. This creates redundancy in the system, if one section gets damaged or one power supply fails, the powered roadway will still function at close to full capacity. This approach also makes installation simpler. The three phase unipolar track allows significantly better horizontal tolerance with a small increase in cost and copper losses.
Patent NZ-588943-A (NZ)
Title: Dough moulder comprising a movable diverter to allow dough to be fed into desirable pair of sheeting rollers
Inventor: PAUL EATON WILLETT
IPC: A21C1/08
Filed: 2010-11-01
Abstract: Pining system for dough moulder with a pivotally mounted diverter (13) is disclosed. The dough moulder has a first set of sheeting rollers (1 and 5) and second set of sheeting rollers (6 and 7). There is an inlet (18) that provides a path for receiving dough (4') from an operator. The system is characterised by a pivotally mounted diverter (13) that is movable by the operator to place the dough (4') from the inlet (18) to a selected one of the first set of sheeting rollers (1 and 5) or second set of sheeting rollers (6 and 7).
Patent NZ-589365-A (NZ)
Title: Peptidyl diacylglycerides
Inventor: THACKER JAMES D
IPC: A61K38/10
Filed: 2009-04-24
Abstract: NZ 589365 Disclosed is a compound comprising a peptide having an amino acid sequence from a group consisting of XLYDKGYTSKEQKDCVGIX or XLYDKGYTPKEQKDCVGIX, the compound being further characterised in that the N-terminal X is Q or is N-acetyl alanine and the C-terminal amino acid X is not F.
Patent NZ-595004-A (NZ)
Title: A cushioning pad
Inventor: WOOD JOHN
IPC: A41D13/06
Filed: 2010-02-05
Abstract: 595004 A cushioning pad (110) comprising a structure defining longitudinal first passageways (116), each longitudinal passageway defining a longitudinal axis. The structure being such that the passageways and longitudinal axes thereof intersect with a support surface of said pad which is arranged to support an applied load. The pad further includes a sheet member (150) which is positioned substantially within the structure. The sheet member is convex in profile, so that the apex of the arc of the sheet member faces towards the support surface. The sheet member is made from an elastomer so that the sheet member acts as a leaf spring, thereby providing additional resilience to the structure.
Patent NZ-597916-A (NZ)
Title: Benzoquinolizinium salt derivatives as anticancer agents
Inventor: ARCAMONE ANDREA GUIDO
IPC: A61K31/473
Filed: 2010-07-06
Abstract: Disclosed are 13-substituted 5,6-dihydrodibenzo[a,g]quinolizinium salt compounds according to Formula (I) and methods for their preparation. Specific examples of compounds of Formula (I) include: 13-[2-(phenyl)ethyl]-9,10-dimethoxy-5,6-dihydrobenzo[g]-1,3-benzodioxolo[5,6-a]quinolizinium iodide, 13-[2-(naphth-1-yl)ethyl]-9,10-dimethoxy-5,6-dihydrobenzo[g]-1,3-benzodioxolo[5,6-a]quinolizinium iodide, 13-[3-(4-chlorophenyl)propyl]-9,10-dimethoxy-5,6-dihydrobenzo[g]-1,3-benzodioxolo[5,6-a]quinolizinium iodide, and 13-[(4-pyridyl)carbonylaminomethyl]-9,10-dimethoxy-5,6-dihydrobenzo[g]-1,3-benzodioxolo[5,6-a]quinolizinium iodide. Compounds of formula (I) are in the class of protoberberines and are useful for treating cancer.
Patent NZ-598243-A (NZ)
Title: An oven for heat-treating food pieces
Inventor: IVERSEN PER HEINDORF
IPC: A23L19/18
Filed: 2010-07-12
Abstract: An oven serves for heat-treating food pieces laid upon a grid (13) in a cabinet (1) by means of a heat source (34). The grid consists of an upper part (13) of an endless chain running around a number of chain supports ( 42, 43, 44) of which a lower and upper support (42, 43) is defining a lower and upper end of said upper chain part. Portions of food pieces can by means of the oven quickly and easily and in a simple and economical manner be heat-treated in rapid succession. The direction of rotation can be reversed for discharge of the food pieces.
Patent NZ-599877-A (NZ)
Title: Hdx demodulator
Inventor: BATEMAN LEIGH
IPC: H04B1/59
Filed: 2010-10-12
Abstract: 599877 Disclosed is a process for demodulating a low frequency HDX FSK signal (902). The process involves receiving the HDX FSK signal (902) using a resonant antenna (903) and upwardly mixing the FSK signal (902) to an intermediate frequency by mixing the HDX FSK signal (902) with a fixed local oscillator frequency. The intermediate frequency FSK signal is filtered using at least one ceramic band pass filter (908, 910) and is then demodulated to produce a binary output (912). The HDX FSK frequencies are 134.2 KHz and 124.2 KHz.
Patent NZ-615067-A (NZ)
Title: Hepatitis c virus inhibitors
Inventor: BENDER JOHN A
IPC: A61P31/14
Filed: 2012-02-02
Abstract: The disclosure relates to imidazole-pyrrolidinediyl-pyran-biscarbamate derivatives of formula (I), wherein the variables are as defined in the specification, which are suitable for inhibiting hepatitis C virus. Also disclosed are pharmaceutical compositions containing such compounds and methods for using these compounds in the treatment of HCV infection.
Patent NZ-619995-A (NZ)
Title: Apparatus for foaming a liquid
Inventor: BARTH VOLKER
IPC: B05B7/26
Filed: 2012-07-26
Abstract: An apparatus for foaming a liquid is disclosed. The apparatus includes a pump for pumping an aerated liquid to an outlet via a conduit (7). The conduit (7) includes at least one flow resistor which encloses a plurality of adjacent elastic resistor elements (20a) which are movable relative to one another and form passages for the liquid to pass. The resistor elements (20a) are supported against a support (27) and are compressed against the support (27) by the pressure forces (26) of the liquid forced through the resistor. The resistor reduces pressure pulses caused by the pump. The apparatus may be used for frothing milk for a beverage.
Patent NZ-624712-A (NZ)
Title: Compositions and methods for modulation of smn2 splicing in a subject
Inventor: HUA YIMIN
IPC: A61K31/7088
Filed: 2010-06-17
Abstract: Disclosed is the use of an antisense compound comprising an antisense oligonucleotide complementary to intron 7 of a nucleic acid encoding human SMN2 pre-mRNA, wherein each nucleoside of the antisense oligonucleotide comprises a modified sugar moiety, wherein each modified sugar moiety is a 2’-methoxyethyl sugar moiety, in the manufacture of a medicament for use in treating a disease or condition associated with survival motor neuron 1 (SMN1) in a subject, wherein the medicament is formulated for administration of the antisense compound at a dose from 0.01 to 10 milligrams of antisense compound per kilogram of body weight of the subject, and wherein the medicament is formulated for administration other than into the cerebrospinal fluid.
Patent NZ-627368-A (NZ)
Title: Time released biodegradable or bioerodible microspheres or microparticles suspended in a solidifying depot-forming injectable drug formulation
Inventor: MARSH DAVID A
IPC: A61K47/34
Filed: 2013-01-22
Abstract: The disclosure relates to a composite drug delivery material comprising a plurality of microparticles dispersed in a media composition; wherein the microparticles comprise: a drug; and a coating comprising a bioerodible material or a biodegradable material; and wherein the media composition comprises the drug dispersed in a depot forming material; and wherein the media composition is in a liquid form before administration and is configured to substantially increase in viscosity during or after being injected into a body of a mammal, so that the form of the media after injection is a solid or a gel. The disclosure also relates to the use of these in treating an ocular disease or injury.
Patent NZ-629711-A (NZ)
Title: Anti-inflammatory compositions, methods and uses thereof
Inventor: GREGOR STEINHORN
IPC: A61P29/00
Filed: 2013-08-30
Abstract: Disclosed is the use of an anti-inflammatory activity less than or equal to 10kDa fraction obtained from honey in the manufacture of a medicament for the treatment of a skin condition, stomach ulcer and/or digestive condition in a subject in need thereof.
Patent NZ-630580-A (NZ)
Title: 6-(4-(1-amino-3-hydroxycyclobutyl)phenyl)-5-phenyl(furo,thieno or pyrrolo) [2, 3-d] pyrimidin-4-one derivatives for the treatment of cancer
Inventor: HARRISON TIMOTHY
IPC: C07D495/04
Filed: 2013-03-25
Abstract: Disclosed are compounds of Formula (I) that are useful as inhibitors of the activity of one or more isoforms of the serine / threonine kinase AKT. The present invention also relates to pharmaceutical compositions comprising these compounds and to methods of using these compounds in the treatment of cancer and methods of treating cancer. Examples of a compound of formula (I) are: 6-(4-((1s,3s)-1-amino-3-hydroxy-3-methylcyclobutyl)phenyl)-5-phenyl-3-(2,2,2-trifluoroethyl)furo[2,3-d]pyrimidin-4(3H)-one 6-(4-((1r,3r)-1-amino-3-hydroxy-3-methylcyclobutyl)phenyl)-7-methyl-5-phenyl-3-(2,2,2-trifluoroethyl)-3H-pyrrolo[2,3-d]pyrimidin-4(7H)-one
Patent NZ-631309-A (NZ)
Title: High pressure fluid spray nozzle incorporating a flow controlled switching valve
Inventor: ZINK GERALD P
IPC: F16K11/07
Filed: 2012-02-06
Abstract: Disclosed is a high pressure fluid spray nozzle containing a flow controlled switching valve that incorporates a poppet member. The nozzle comprises a hollow body having a central bore, one or more first ports, and one or more second ports, wherein each first and second port extends through the body from the central bore; and a switching valve cartridge including a poppet and a guide disposed in the central bore, wherein the poppet and guide cooperate to direct fluid flow from an inlet to the central bore to the one or more first ports upon application of fluid flow above a predetermined threshold to the inlet to the central bore and, if fluid flow drops below a predetermined threshold, direct fluid flow from the inlet to the central bore to the one or more second ports when fluid flow is next applied above the predetermined threshold. The poppet is located at a first position when fluid flow is directed through the one or more first ports and at a second position when fluid flow is directed through the one or more second ports. The poppet is at a third position whenever fluid flow drops below the predetermined threshold. The poppet at the first position directs fluid flow through a first set of the first ports and directs fluid flow through a second set of the second ports at the second position. Each transition below the predetermined threshold causes the fluid flow to alternate between the first and second sets of ports.
Patent NZ-631348-A (NZ)
Title: Modified human rotaviruses and uses therefor
Inventor: KIRKWOOD CARL
IPC: C12N15/01
Filed: 2013-08-26
Abstract: Disclosed is an isolated Vero-adapted rotavirus (RV) RV3 comprising at least one mutation selected from the group consisting of: - a mutation in NSP4 protein of MA104 53A to Vero 53T, MA104 76I to Vero 76T and MA104 165P to Vero 165L; - a mutation in NSP5 protein of MA104 46G to Vero 46E and MA104 112L to Vero 112I; - a mutation in VP1 protein of MA104 886V to Vero 886F; - a mutation in VP3 protein of MA104 643E to Vero 643K and MA104 785Y to Vero 785H; - a mutation in VP4 protein of MA104 374L to Vero 374S, MA104 388I to Vero 388L, MA104 442R to Vero 442H and MA104 756N to Vero 756I - a mutation in NSP2 gene of MA104 387G to Vero 433A; - a mutation in NSP4 gene of MA104 157G to Vero 197A, MA104 227T to Vero 267C and MA104 494C to Vero 534T - a mutation in NSP5/6 gene of MA104 137G to Vero 158A, MA104 144T to Vero 165C and MA104 334T to Vero 355A - a mutation in VP1 gene of MA104 2656G to Vero 2692T - a mutation in VP3 gene of MA104 294T to Vero 343C, MA104 1317A to Vero 1366G, MA104 1695T to Vero 1744C, MA104 1927G to Vero 1976A and MA104 2353T to Vero 2402C; and - a mutation in VP4 gene of MA104 1121T to Vero 1130C, MA104 1162A to Vero 1171C and MA104 2267A to Vero 2276T. Also disclosed is a method for culturing rotavirus (RV) strain RV3, said method comprising incubating an aliquot or inoculum of RV3 with a higher concentration of trypsin relative to other RV activation protocols and culturing the trypsin treated RV3 in Vero cells until the RV3 to undergo genetic modification relative to MA104-adapted RV3, wherein the genetic modification are as disclosed in the complete specification.
Patent NZ-702182-A (NZ)
Title: Positioning and nesting device for premature neonates in nicu
Inventor: MARLENE DU TOIT PARKS
IPC: A61G11/00
Filed: 2016-10-04
Abstract: An objective of the present invention is to provide a device that will facilitate the safe, comfortable and developmentally appropriate positioning of premature neonates in NICU whilst nursed/cared for in a cot and/or incubator (on already existing mattresses), or that at least provides a useful alternative to current positioning practices. The device includes a main member which has an oblong shaped boundary, rounded corners with openings to place tubing etc. into, encased by heat and water resistant, recycled material; filled by recycled, mouldable, heat and water resistant, non-toxic material/fibers/pellets. The above device’s main member is encased by a second layer of natural, absorbent, soft material/fabric over which a removable ‘fitted sheet’ with elastic at the ends made from natural material/fibers (to enhance and support the skin integrity of the premature neonate) is placed. The sides and base is movable and shape retaining to support the premature neonate’s position whilst nursed in an incubator and/or a cot in NICU.